Delivery Order SPE2DR25D1205-SPE2DR26F0VW3
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Arformoterol 15 mcg/2 ml solution. The contract has a ceiling value of $3,245.70 and is scheduled to be completed by April 4, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML, a medical product. The contract has a Ceiling Value of $1,218.25 and an Ultimate Completion Date of April 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,038.26, is for the provision of ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 14, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,785.70 firm fixed-price delivery order is for the supply of Arformoterol 15 mcg/2 ml solution, a pharmaceutical product used in the treatment of respiratory conditions. The contract has an ultimate completion date of September 18, 2024 and was awarded on September 17, 2024. This award does not utilize a set-aside designation. Amerisourcebergen,...
- The Defense Logistics Agency Troop Support Medical awarded a $780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561501841 ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from July 14, 2023 through July 17, 2023 to provide the specified pharmaceutical product. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,079.94 firm fixed-price delivery order is for the supply of ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML, a medication used for the treatment of respiratory conditions. The award is not associated with a specific set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,467.28 firm fixed-price delivery order is for the supply of Arformoterol 15 mcg/2 ml solution, a respiratory medication, to support the healthcare needs of military personnel and other federal beneficiaries. The award is not associated with any set-aside designation and is part of a larger Indefinite...
- This firm fixed-price delivery order for $829.81 was awarded by the Defense Logistics Agency Troop Support (DLA Troop Support) to Amerisourcebergen Drug Corporation to supply 15 mcg/2 ml solutions of arformoterol. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, and delivery is required between August 29-30, 2023. DLA Troop Support manages the Medical Prime Vendor program to provide medical supplies and pharmaceuticals to support military treatment...
- This federal contract award, valued at $2,106.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565483180 - ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML. The contract is a delivery order with a firm fixed price, and the ultimate completion date is August 19, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $4,163.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the delivery of 4566066447 ARFORMOTEROL 15 MCG/2 ML SOLN UD 2ML. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen is a significant supplier of pharmaceutical products and medical supplies to various government agencies, including the DLA,...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VW3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Arformoterol 15 mcg/2 mL solution in unit dose 2 mL vials, with a ceiling value of $1,657.02. This is a firm fixed price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The contract carries no set-aside designation and represents a competitively awarded transaction. Performance is to be completed by October 29, 2025, with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor supplying medications and medical supplies to military and veteran healthcare systems. The broader SPE2DX contract vehicle enables AmerisourceBergen to furnish a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. This delivery order for Arformoterol, a respiratory medication used in asthma and chronic obstructive pulmonary disease management, exemplifies the company's role in fulfilling routine pharmaceutical procurement requirements within the Defense Health Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/28/25 |